Is CNS Pharmaceuticals, Inc. (CNSP) a Buy, Sell, or Hold?
NASDAQ : CNSP
CNS Pharmaceuticals, Inc. — Institutional Ownership
$5.38 USD
$0.14 (2.77%)
- Volume
- 1.97K
- Average Volume
- 1.43M
- Market Capitalization
- $7.86M
- P/E Ratio
- -0.18
- Dividend Yield
- 0.00%
- Price Target
- $0.50
- Year High
- $10.59
- Year Low
- $1.90
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.88
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-05-15 | Stonepine Capital Management, LLC | 159.79K | 9.90% |
| 2026-04-17 | Ikarian Capital, LLC | 45830.0 | 5.70% |
| 2026-02-13 | Stonepine Capital Management, LLC | 48827.0 | 7.90% |
| 2025-11-14 | Armistice Capital, LLC | 30177.0 | 4.99% |
| 2025-11-04 | Stonepine Capital Management, LLC | 32220.0 | 5.60% |
| 2025-08-14 | Armistice Capital, LLC | 561.15K | 9.99% |
| 2024-08-02 | Cortice Biosciences, Inc. | 573.37K | 5.70% |
| 2024-07-02 | Robert Forster | - | 0.00% |
| 2023-08-01 | Waldemar Priebe | 6667.0 | 0.30% |
| 2023-08-01 | Kewat, LLC | - | 0.00% |
| 2023-02-14 | Steven Boyd | 165.46K | 9.99% |
| 2023-02-14 | Armistice Capital, LLC | 165.46K | 9.99% |
CNSP Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $5.25 | 443.37K | $2.33M | $7.2M | $328.57K | -$4.54M |
| 2024-12-31 | $72.24 | 31853 | $2.3M | $6.46M | $326.07K | -$3.83M |
| 2023-12-31 | $38100.00 | 125 | $4.76M | $548.72K | $300.81K | $4.51M |
| 2022-12-31 | $72000.00 | 45 | $3.24M | $10.06M | $409.97K | -$6.41M |
| 2021-12-31 | $632160.00 | 29 | $18.33M | $5M | $387.79K | $13.72M |
| 2020-12-31 | $1602000.00 | 18 | $28.84M | $14.04M | $439.29K | $15.24M |
| 2019-12-31 | $3555000.00 | 18 | $63.99M | $7.24M | -$ | $56.75M |
| 2018-12-31 | $4113000.00 | 18 | $74.03M | $282.74K | $316.92K | $74.07M |
| 2017-12-31 | $4113000.00 | 18 | $74.03M | $110.54K | $121.82K | $74.05M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2.39 | 676.17K | $1.62M | $2.95M | $232.35K | -$1.1M |
| 2025-12-31 | $5.25 | 443.37K | $2.33M | $7.2M | $328.57K | -$4.54M |
| 2025-09-30 | $9.00 | 558.87K | $5.03M | $9.86M | $30793 | -$4.8M |
| 2025-06-30 | $9.90 | 370.13K | $3.66M | $12.13M | $121.77K | -$8.34M |
| 2025-03-31 | $16.32 | 227.22K | $3.71M | $13.05M | $210.67K | -$9.13M |
| 2024-12-31 | $72.24 | 117.8K | $8.51M | $6.46M | $326.07K | $2.37M |
| 2024-09-30 | $78.36 | 36968 | $2.9M | $6.97M | $31187 | -$4.05M |
| 2024-06-30 | $852.00 | 627 | $534.2K | $1.49M | $123.25K | -$834.11K |
| 2024-03-31 | $10794.00 | 290 | $3.13M | $815.23K | $213.1K | $2.53M |
| 2023-12-31 | $38100.00 | 187 | $7.12M | $548.72K | $300.81K | $6.88M |
| 2023-09-30 | $34200.00 | 139 | $4.75M | $909.55K | $41904 | $3.89M |
| 2023-06-30 | $66900.00 | 129 | $8.63M | $4.28M | $166.4K | $4.52M |